Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant fusion protein linking coagulation factor VIIa with albumin

EU orphan designation number: EU/3/13/1188   
Active ingredient: Recombinant fusion protein linking coagulation factor VIIa with albumin
Indication: Treatment of congenital factor VII deficiency
Sponsor: CSL Behring GmbH
Emil-von-Behring-Straße 76, 35041 Marburg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2013 Orphan designation EMA/OD/051/13 (2013)6733 of 07/10/2013